Show simple item record

dc.contributor.authorChristidis, D
dc.contributor.authorMcGrath, S
dc.contributor.authorPerera, M
dc.contributor.authorManning, T
dc.contributor.authorBolton, D
dc.contributor.authorLawrentschuk, N
dc.date.accessioned2020-12-22T05:38:14Z
dc.date.available2020-12-22T05:38:14Z
dc.date.issued2017-06-01
dc.identifierpii: S2287-8882(17)30001-6
dc.identifier.citationChristidis, D., McGrath, S., Perera, M., Manning, T., Bolton, D. & Lawrentschuk, N. (2017). Minimally invasive surgical therapies for benign prostatic hypertrophy: The rise in minimally invasive surgical therapies. PROSTATE INTERNATIONAL, 5 (2), pp.41-46. https://doi.org/10.1016/j.prnil.2017.01.007.
dc.identifier.issn2287-8882
dc.identifier.urihttp://hdl.handle.net/11343/258331
dc.description.abstractThe prevalence of benign prostatic hypertrophy (BPH) causing bothersome lower urinary tract symptoms increases with our ageing population. Treatment of BPH traditionally begins with medical therapy and surgical intervention is then considered for those whose symptoms progress despite treatment. Minimally invasive surgical therapies have been developed as an intermediary in the treatment of BPH with the aim of decreasing the invasiveness of interventions. These therapies also aim to reduce morbidity and dysfunction related to invasive surgical procedures. Multiple treatment options exist in this group including mechanical and thermo-ablative strategies. Emerging therapies utilizing differing technologies range from the established to the experimental. We review the current literature related to these minimally invasive therapies and the evidence of their effectiveness in treating BPH. The role of minimally invasive surgical therapies in the treatment of BPH is still yet to be strongly defined. Given the experimental nature of many of the modalities, further study is required prior to their recommendation as alternatives to invasive surgical therapy. More mature evidence is required for the analysis of durability of effect of these therapies to make robust conclusions of their effectiveness.
dc.languageEnglish
dc.publisherELSEVIER INC
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0
dc.titleMinimally invasive surgical therapies for benign prostatic hypertrophy: The rise in minimally invasive surgical therapies
dc.typeJournal Article
dc.identifier.doi10.1016/j.prnil.2017.01.007
melbourne.affiliation.departmentSurgery (Austin & Northern Health)
melbourne.affiliation.department
melbourne.source.titleProstate International
melbourne.source.volume5
melbourne.source.issue2
melbourne.source.pages41-46
dc.rights.licenseCC BY-NC-ND
melbourne.elementsid1192879
melbourne.contributor.authorLawrentschuk, Nathan
melbourne.contributor.authorPerera, Marlon Lakmal
melbourne.contributor.authorBolton, Damien
dc.identifier.eissn2287-903X
melbourne.accessrightsOpen Access


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record